resveratrol has been researched along with Heart Diseases in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.23) | 18.2507 |
| 2000's | 12 (38.71) | 29.6817 |
| 2010's | 13 (41.94) | 24.3611 |
| 2020's | 5 (16.13) | 2.80 |
| Authors | Studies |
|---|---|
| Li, B; Li, W; Liu, Z; Tang, Z; Tian, C; Yu, D; Yu, J | 1 |
| Jojima, K; Node, K; Tanaka, A | 1 |
| Akgun-Unal, N; Baltaci, AK; Baltaci, SB; Mogulkoc, R; Ozyildirim, S; Unal, O | 1 |
| Timm, KN; Tyler, DJ | 1 |
| Apaijai, N; Arinno, A; Chattipakorn, N; Chattipakorn, SC | 1 |
| Huang, Z; Kong, J; Qiu, Y; Shen, F; Wang, L; Wang, W; Xiong, Z; Yang, Y | 1 |
| Bartolomucci, A; Beker, DL; Dyck, JRB; Grant, MK; Hamza, SM; Matsumura, N; Parajuli, N; Razzoli, M; Robertson, IM; Soltys, CM; Zordoky, BN | 1 |
| Dolinsky, VW; Dyck, JR; Haykowsky, MJ; Jones, LW; Rogan, KJ; Sung, MM; Young, ME; Zordoky, BN | 1 |
| Hollingsworth, A; Khurana, S; Piche, M; Tai, TC; Venkataraman, K | 1 |
| Bocchi, L; Bresciani, L; Brighenti, F; Calani, L; Del Rio, D; Delucchi, F; Ray, S; Savi, M; Stilli, D | 1 |
| Gao, Y; Kang, L; Li, C; Li, Q; Liu, R; Sun, C; Wang, J; Wang, X | 1 |
| Mashghoolozekr, E; Mozafari, M; Nekooeian, AA; Panjeshahin, MR | 1 |
| Cetinel, S; Sehirli, O; Sener, G; Süleymanoğlu, S; Tatlidede, E; Velioğlu-Oğünc, A; Yarat, A; Yeğen, BC | 1 |
| Bertelli, AA; Das, DK | 1 |
| Anton, SD; Bernabei, R; Carter, CS; Leeuwenburgh, C; Marzetti, E; Wohlgemuth, SE | 1 |
| Wu, JM | 1 |
| Aouani, E; Ghanem-Boughanmi, N; Sani, M; Sebai, H | 1 |
| Louis, XL; MohanKumar, SK; Netticadan, T; Taylor, CG; Thandapilly, SJ; Yu, L; Zahradka, P | 1 |
| Netticadan, T | 1 |
| Delibaşı, T; Karadeniz, C; Oğuz, A; Okur, A; Pınarlı, FA; Pınarlı, FG; Sönmez, D; Turan, NN; Ulus, T | 1 |
| Ansari, MA; Bakheet, SA; El-Kadi, AO; Korashy, HM; Maayah, ZH | 1 |
| Somoza, V | 1 |
| Baur, JA; Sinclair, DA | 1 |
| Csiszar, A; Lerea, K; Stef, G; Ungvari, Z; Veress, G | 1 |
| Bagchi, D; Das, DK; Juhasz, B; Koneru, S; Maulik, N; Otani, H; Penumathsa, SV; Thirunavukkarasu, M; Zhan, L | 1 |
| Han, XZ; Lou, HX; Yu, BB | 1 |
| Alcendor, RR; Hsu, CP; Odewale, I; Sadoshima, J | 1 |
| Baxter, RA | 1 |
| Chai, LM; Chen, JX; Du, ZM; Li, GY; Liu, Y; Lu, YJ; Yang, BF; Zhang, Y; Zhao, XY | 1 |
| Bagchi, D; Bagchi, M; Das, DK; Kothari, SC; Tosaki, A | 1 |
9 review(s) available for resveratrol and Heart Diseases
| Article | Year |
|---|---|
Resveratrol against Cardiac Fibrosis: Research Progress in Experimental Animal Models.
Topics: Animals; Antifibrotic Agents; Antioxidants; Disease Models, Animal; Heart; Heart Diseases; Humans; Myocardium; Resveratrol | 2021 |
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Antibiotics, Antineoplastic; Caloric Restriction; Cardiotoxicity; Doxorubicin; Enzyme Activation; Enzyme Activators; Exercise; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Mitochondria, Heart; Myocytes, Cardiac; Resveratrol; Ribonucleotides; Signal Transduction; Thiazolidinediones | 2020 |
The roles of resveratrol on cardiac mitochondrial function in cardiac diseases.
Topics: Antioxidants; Heart Diseases; Humans; Mitochondria; Oxidative Stress; Reactive Oxygen Species; Resveratrol; Stilbenes | 2021 |
Polyphenols: benefits to the cardiovascular system in health and in aging.
Topics: Aging; Animals; Cardiovascular System; Catechin; Curcumin; Diet; Disease Models, Animal; Fruit; Heart Diseases; Humans; Olive Oil; Plant Oils; Polyphenols; Quercetin; Randomized Controlled Trials as Topic; Reactive Oxygen Species; Resveratrol; Stilbenes | 2013 |
Grapes, wines, resveratrol, and heart health.
Topics: Cardiotonic Agents; Heart Diseases; Humans; Longevity; Resveratrol; Stilbenes; Vitis; Wine | 2009 |
Cellular mechanisms of cardioprotection by calorie restriction: state of the science and future perspectives.
Topics: Aged; Animals; Antioxidants; Apoptosis; Autophagy; Caloric Restriction; Cardiovascular Diseases; Disease Models, Animal; Forecasting; Heart Diseases; Homeostasis; Humans; Inflammation; Inflammation Mediators; Mitochondria, Heart; Mitochondrial Diseases; Obesity; Oxidation-Reduction; Oxidative Stress; Resveratrol; Stilbenes | 2009 |
Therapeutic potential of resveratrol: the in vivo evidence.
Topics: Aging; Animals; Heart Diseases; Humans; Inflammation; Myocardial Infarction; Neoplasms; Protective Agents; Resveratrol; Stilbenes; Stroke | 2006 |
Sirt1 protects the heart from aging and stress.
Topics: Aging; Animals; Apoptosis; Caloric Restriction; Heart; Heart Diseases; Heart Failure; Humans; Longevity; Mice; Nicotinamide Phosphoribosyltransferase; Oxidative Stress; Resveratrol; Saccharomyces cerevisiae; Sirtuin 1; Sirtuins; Stilbenes; Up-Regulation | 2008 |
Anti-aging properties of resveratrol: review and report of a potent new antioxidant skin care formulation.
Topics: Aging; Alzheimer Disease; Animals; Antioxidants; Heart Diseases; Humans; Resveratrol; Sirtuins; Skin Aging; Stilbenes; Wine | 2008 |
22 other study(ies) available for resveratrol and Heart Diseases
| Article | Year |
|---|---|
Resveratrol supplementation: a therapeutic potential for cardiac remodeling in hypertensive heart disease.
Topics: Dietary Supplements; Heart Diseases; Humans; Hypertension; Resveratrol; Ventricular Remodeling | 2023 |
The effects of resveratrol and melatonin on cardiac dysfunction in diabetic elderly female rats.
Topics: Animals; Diabetes Mellitus, Experimental; Female; Heart Diseases; Melatonin; Papillary Muscles; Rats; Resveratrol | 2023 |
Topics: Animals; Antioxidants; Apoptosis; Cardiotonic Agents; Cardiotoxicity; Cell Line; Diterpenes; Epoxy Compounds; Female; Forkhead Box Protein O3; Heart Diseases; Humans; Male; Mice; Mice, Inbred BALB C; Myocardium; Myocytes, Cardiac; Phenanthrenes; Resveratrol; Signal Transduction; Sirtuin 3; Stilbenes | 2016 |
Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.
Topics: Adaptation, Physiological; Angiotensin II; Animals; Blood Pressure; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Enzyme Activation; Heart Diseases; Hypertension; Male; Mice, Inbred C57BL; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Resveratrol; Signal Transduction; Time Factors; Ventricular Remodeling | 2018 |
Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Biomarkers; Blood Pressure; Blotting, Western; Dietary Supplements; Doxorubicin; Electron Transport Chain Complex Proteins; Female; GTP Phosphohydrolases; Heart Diseases; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Mitochondria, Heart; Physical Conditioning, Animal; Resveratrol; Stilbenes; Ventricular Dysfunction, Left | 2013 |
Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats.
Topics: Animals; Biotransformation; Blood Glucose; Body Weight; Cardiotonic Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Glucuronides; Heart Diseases; Hemodynamics; Male; Myocardium; Rats, Wistar; Resveratrol; Stilbenes; Sulfates; Time Factors | 2014 |
Resveratrol Ameliorates Diabetes-Induced Cardiac Dysfunction Through AT1R-ERK/p38 MAPK Signaling Pathway.
Topics: Animals; Diabetes Mellitus, Experimental; Heart Diseases; Male; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Resveratrol; Stilbenes | 2016 |
The cardioprotective effects of resveratrol in rats with simultaneous type 2 diabetes and renal hypertension.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Heart Diseases; Hypertension, Renal; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2015 |
Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage.
Topics: Animals; Antioxidants; Blood Pressure; Catalase; Doxorubicin; Glutathione; Heart Diseases; Heart Rate; Luminescent Measurements; Malondialdehyde; Myocardium; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase | 2009 |
Resveratrol alleviates some cardiac dysfunction indexes in an SHR model of essential hypertension.
Topics: Animals; Antioxidants; Cardiomegaly; Cardiotonic Agents; Chronic Disease; Heart Diseases; Heart Failure; Hypertension; Myocardial Contraction; Rats; Rats, Inbred SHR; Resveratrol; Stilbenes | 2010 |
Cardioprotective effect of resveratrol on lipopolysaccharide-induced oxidative stress in rat.
Topics: Animals; Antioxidants; Catalase; Disease Models, Animal; Endotoxemia; Heart; Heart Diseases; Lipid Peroxidation; Lipopolysaccharides; Male; Myocardium; Nitric Oxide; Oxidative Stress; Peroxidase; Rats; Reactive Oxygen Species; Resveratrol; Stilbenes; Superoxide Dismutase | 2011 |
Treatment with low-dose resveratrol reverses cardiac impairment in obese prone but not in obese resistant rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biomarkers; Blood Glucose; Diet, High-Fat; Disease Resistance; Disease Susceptibility; Echocardiography; Heart; Heart Diseases; Hyperglycemia; Hyperinsulinism; Male; Obesity; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2012 |
Why research on resveratrol-mediated cardioprotection should not decelerate.
Topics: Animals; Cardiotonic Agents; Heart; Heart Diseases; Humans; Research Design; Resveratrol; Stilbenes | 2012 |
Resveratrol and adipose-derived mesenchymal stem cells are effective in the prevention and treatment of doxorubicin cardiotoxicity in rats.
Topics: Adipose Tissue; Animals; Antibiotics, Antineoplastic; Cell Proliferation; Doxorubicin; Female; Heart Diseases; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2013 |
The role of aryl hydrocarbon receptor signaling pathway in cardiotoxicity of acute lead intoxication in vivo and in vitro rat model.
Topics: Animals; Blotting, Western; Creatine Kinase; Cytochrome P-450 CYP1A1; Heart; Heart Diseases; Histocytochemistry; L-Lactate Dehydrogenase; Lead; Male; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Random Allocation; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Aryl Hydrocarbon; Resveratrol; RNA, Messenger; Signal Transduction; Stilbenes | 2013 |
MAGIC-OL Resveratrol.
Topics: Diet; Fruit; Health Promotion; Heart Diseases; Humans; Resveratrol; Stilbenes | 2005 |
Resveratrol inhibits aggregation of platelets from high-risk cardiac patients with aspirin resistance.
Topics: Adult; Aged; Aspirin; Drug Resistance; Female; Heart Diseases; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Resveratrol; Stilbenes | 2006 |
Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase.
Topics: Animals; Apoptosis; Blood Glucose; Diabetes Mellitus, Experimental; Gene Expression Regulation; Heart Diseases; Heme Oxygenase (Decyclizing); In Situ Nick-End Labeling; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Resveratrol; RNA, Messenger; Stilbenes; Streptozocin; Superoxide Dismutase; Thioredoxins; Vascular Endothelial Growth Factor A | 2007 |
Oligomers of resveratrol and ferulic acid prepared by peroxidase-catalyzed oxidation and their protective effects on cardiac injury.
Topics: Animals; Cell Line; Coumaric Acids; Fruit; Heart; Heart Diseases; Momordica charantia; Myocardium; Oxidation-Reduction; Peroxidase; Rats; Resveratrol; Stilbenes | 2007 |
Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Arsenic Trioxide; Arsenicals; Calcium; Caspase 3; Cell Survival; Cytoplasm; Electrocardiography; Female; Heart Diseases; In Situ Nick-End Labeling; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Myocytes, Cardiac; Oxidative Stress; Oxides; Reactive Oxygen Species; Resveratrol; Stilbenes | 2008 |
Benefits of the grape.
Topics: Antioxidants; Heart Diseases; Humans; Male; Neoplasms; Resveratrol; Rosales; Stilbenes; Wine | 1999 |
Benefits of resveratrol in women's health.
Topics: Animals; Anthocyanins; Anticarcinogenic Agents; Antioxidants; Dose-Response Relationship, Drug; Estrogens, Non-Steroidal; Female; Free Radicals; Heart Diseases; Humans; Isoflavones; Phytoestrogens; Plant Preparations; Proanthocyanidins; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Stilbenes; Ventricular Fibrillation | 2001 |